Introduction
In recent years, lung cancer has become the leading cause of cancer deaths for both men and women in China. The incidence and death rate of lung cancer in urban populations have reached the number one among malignant tumors (1) . It would worsen if smoking rates continue their upward trend (2) . Cigarette smoking accounts for an estimated 30% of all cancer deaths and Ͼ80% of deaths from lung cancer (3, 4) . Cigarette smoke contains a myriad of genotoxicants and carcinogens, including oxidants which inflict oxidative DNA damages, and the polycyclic aromatic hydrocarbons (PAH), such as benzo [a] 
pyrene (B[a]P) which could be bioactivated in vivo
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© Oxford University Press 1321 into benzo[a]pyrene-diol-epoxide (BPDE) and then irreversibly damage DNA by covalent binding or oxidation (5) . While the removal or repair of DNA damage plays a key role in protecting the integrity of the genome from the insults of cancer-causing agents. Individuals with DNA repair defects might be at a higher risk of cancer (6) (7) (8) . Some studies have reported significantly reduced DNA repair capacity (DRC) in the patients of lung cancer and squamous cell carcinoma of the head and neck compared with the control population (5, (9) (10) (11) .
A complex system of DNA repair enzymes has a vital role in protecting the genome of the cell from carcinogenic exposure. The DNA repair enzyme X-ray repair cross-complementing group 1 (XRCC1) is thought to be involved in the base excision repair (BER) of oxidative DNA and single strand breaks repair (12) . XRCC1 protein is proposed to interact with poly(ADP-ribose) polymerase and DNA ligase III in recognition and re-joining of DNA strand breaks, and with DNA polymerase β in BER (12) (13) (14) . Phenotype studies demonstrated that early embryonic lethality was associated with knockout of mouse XRCC1 (12, 15) . XRCC1 mutants display sensitivity to alkylating agents and ionizing radiation and exhibit elevated levels of sister chromatid exchange in the Chinese hamster ovary cell lines (16, 17) . Such alterations could be associated with increased cancer risk.
The xeroderma pigmentosum group D (XPD) protein is an evolutionarily conserved helicase, a subunit of transcription factor II H (TFIIH) that is essential for transcription and nucleotide excision repair (NER) (18) . Mutations in XPD prevent its protein product from interacting with p44, another subunit of TFIIH and reduce its heliase activity, resulting in a defect in NER (19) . Studies have shown that XPD is involved in repairing genetic damage induced by carcinogens from cigarette smoke (9) . Shen et al. (20) have identified three polymorphisms of the XRCC1 gene and three polymorphisms of the XPD gene, which resulted in amino acid changes at evolutionarily conserved regions. The functional effects of the polymorphisms in XRCC1 and XPD are not well known. It will be interesting to determine if the function of XRCC1 and XPD is significantly modified by these amino acid changes, resulting in deficient DNA repair that may be responsible for increased cancer susceptibility.
The earlier studies have reported the relationship of XRCC1 polymorphisms at codon 194 and codon 399 and cancer risk or carcinogen-DNA adducts (21, 22) . Recently, XRCC1 polymorphisms in relation to lung cancer risk in Korean, African-Americans and Caucasians were observed (23, 24) . Lunn et al. (25) have shown the frequency distributions of these two polymorphisms of XRCC1 varied remarkably in Caucasians and in Taiwanese. Moreover, several studies showed that XPD codon 751 polymorphisms were associated with lung cancer, basal cell carcinoma and melanoma susceptibility in western population (11, (26) (27) (28) (29) . As about 700 million Chinese people are subject to smoking directly or indirectly (30), which contributes to lung cancer risk, it is indispensable to investigate the effects of the polymorphisms of XRCC1 and XPD on lung cancer susceptibility in a Chinese population, which has not been reported so far. In this report, we describe a case-control study of lung cancer in a Chinese population to explore the contribution of two polymorphic sites of the XRCC1 gene and one of XPD gene to test the hypothesis that genetic polymorphisms of the two genes contribute to host susceptibility to lung cancer.
Materials and methods

Study subjects
In this case-control study, the case group consisted of 109 diagnosed patents (between March 1994 and September 1997) with histologically confirmed lung carcinoma in the Department of Thoracic Surgery at Jiangsu Cancer Hospital, China. Patients with secondary and recurrent tumors were excluded. The control group comprised 109 healthy volunteers. They were obtained from community centers, cancer-screening programs, and were individually matched to the cases by age, gender and smoking status. Data on age, gender, smoking status and amount were derived from questionnaires (Table I) . To be considered a smoker, individuals must have smoked at least 120 cigarettes in their lifetime. Smokers who had quit smoking for Ͼ6 months prior to interview were defined as former smokers. Pack-years were determined by multiplying the number of cigarettes smoked per day by the number of years smoked and dividing that value by 20. Age was dichotomized at the median age of the study population. After informed consent was obtained, each person donated 5 ml of blood in heparinized tubes and stored at -80°C for biomarker testing.
Genotyping
An amount of 200 ml whole blood was employed for DNA extraction (31) . PCR assays were used to amplify exons of XRCC1 and XPD containing the polymorphisms of interest. Amplifications of exons 5-6 and exons 9-10 of XRCC1 (containing polymorphic sites of codon 194 and codon 399, respectively) were carried out according to Sturgis et al. (21) . Amplification of exon 23 of XPD (containing polymorphic sites of codon 751) was performed as described by Lunn et al. (32) . Briefly, PCR mixture 40 ml, consisting of 30 pmol of each primer, 0.2 mM each dNTP and 1ϫ buffer (50 mM KCl, 10 mM Tris-HCl pH 9.0 at 25°C, 0.1% Triton X-100), 2. 
Results
As shown in Table I (Table II) . In our study subjects, the distributions of smoking amount (packyears) were significantly different in cases and controls. Furthermore, our previous study (33) has shown that the polymorphisms of GSTM1 independently affect the genetic susceptibility to lung cancer in the same population. Therefore, we included GSTM1 genotype and pack-years in our final conditional logistic regression model. As shown in Table II (Table IV) .
Discussion
There has been ample epidemiological evidence to indicate that not all individuals similarly exposed to cigarette smoke eventually develop lung cancer. The prevailing concept is that 1323 defects in one or more steps of DNA repair may be an important determinant in carcinogenesis. DNA sequencing has identified three non-conservative changes in human alleles of XRCC1. Most studies have found that XRCC1 codon 399 polymorphism, instead of codon 194 polymorphism, was related to the risk to cancer in western population studies (20, 25, 34, 35) . However, there was no evidence observed in our study that XRCC1 codon 399 Gln allele was associated with lung cancer risk in a Chinese population. In contrast, we found that the 194 Trp/Trp genotype was associated with a borderline increased risk of lung cancer (OR ϭ 3.06; CI 0.94-9.92). We suggested that it might be due to the genetic trait differences. We found the frequencies of XRCC1 codon 194 Trp allele were significantly higher (24.5%) and XRCC1 codon 399 Gln was much less (27.3%) in our study than those in Caucasians (~5 and 35%, respectively) (21, 25, 36) . The remarkable frequency distribution differences between Caucasians and Taiwanese were also reported (25) . These different frequencies of codon 194 and codon 399 may account for their different contributions to lung cancer risk. It is biologically plausible to assume that XRCC1 polymorphism at codon 194 may have functional significance. This polymorphism occurs at conserved evolutionarily sites and the mutations result in amino acid substitution (20) , which may alter the structure of the DNA repair enzyme and accordingly may be associated with a deficiency in DRC. However, the size of our study was marginally adequate, and the mechanisms of XRCC1 codon 194 polymorphism to lung cancer risk need to be further explored in a larger Chinese population. XPD codes for a DNA helicase involved in transcription and NER. Rare XPD mutations result in genetic diseases, such as xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy (37) . XPD polymorphism may also act as a genetic susceptibility factor. Our results suggested that the XPD codon 751 Lys allele contributed to the increased risk of lung cancer (OR ϭ 3.19; CI 1.01-10.07). The amino acid substitution Lys → Gln, which is a change from a basic to a polar amino acid, could possibly improve the function of the XPD protein (20, 27) , and thus acting as protective. Recently Lunn et al. (32) reported that possessing the XPD codon 751 Lys/Lys (wild-type genotype) was associated with an increased risk of exhibiting chromatid aberrations in human lymphocytes. Dybdahl et al. (27) and Tomescu et al. (26) also reported that individuals with the XPD codon 751 Lys/Lys genotype were at higher risk of basal cell carcinoma and melanoma, respectively. On the other hand, Sturgis et al. (28) reported that the XPD 751 Gln/Gln (mutant genotype) was associated with a borderline increased risk for upper aerodigestive tract cancer. Spitz et al. (11) reported that the XPD 751 Gln/Gln genotype was associated with less optimal DRC, while Moller et al. (29) reported no association of the XPD codon 751 polymorphism with DRC. Clearly, it is difficult to detect subtle differences 1324 in DRC due to a single polymorphism of a single gene in a very complex pathway. The inconsistency in the effect of XPD polymorphism at codon 751 in these studies may be also ascribed to the exposure and interaction with other genes participating in DNA damage recognition, repair and cell cycle regulation (18) .
Combined effects of polymorphisms of XRCC1 194 and XPD 751 on lung cancer risk were further analyzed. The results suggested that the individuals with both XRCC1 194 Trp/Trp and XPD 751 Lys allele genotypes seemed to synergistically increase the risk of lung cancer, compared with those with either of them. Because most environmental exposures including cigarette smoke are complex mixed substances, it is plausible that the repair of DNA damage intrigued by these mixed substances need either BER pathway or NER pathway. The failure or diminished DRC on either side may cause the cancer risk. If the failure or diminished DRC happen on both sides, they may both contribute to the elevated risk of cancer.
After stratification for variables, i.e. age, gender, smoking amount and histological type of cases (Table IV) , the XRCC1 194 Trp/Trp genotype was found associated with a significantly increased risk of lung cancer in male group rather than in female group. We noted that all female subjects (total 38) are non-smokers, and the lack of smoking exposure may give little chance to reveal the effect of XRCC1 codon 194 polymorphism. David-Beabes and London (24) observed somewhat decreased risk of lung cancer for the African-American and Caucasian subjects in Los Angeles County, smoking 20ϩ cigarettes/day and carrying codon 194 Trp alleles. But we could not find whether cigarette consumption may modify the risk of lung cancer, due to insufficient subjects in the smoking amount subgroups. The XPD 751 Lys allele was associated with elevated risk of lung cancer in younger group, who tended to be more liable to the subtle XPD codon 751 genotypic differences after relatively minor environmental exposures to carcinogens. But again, our results may be biased by the relatively small number of subjects in the various subgroups and, therefore, limited the interpretation of this founding. Further studies with larger samples and more complete measures of tobacco exposure (PAH-adducts) would be needed to confirm these preliminary findings.
In brief, to our knowledge, this is the first report of XRCC1 and XPD polymorphisms in relation to lung cancer risk in a case-control study in Chinese population. The results suggested that XRCC1 194 Trp/Trp and XPD 751 Lys allele might be the risk genotypes for lung cancer in Chinese population. Further mechanistic studies of these proteins are needed to enhance our ability to identify those individuals most susceptible to lung carcinogenesis.
